
By BY REBECCA ROBBINS AND CARL ZIMMER from NYT Health If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness. https://ift.tt/3lnhk2t
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
Hiç yorum yok:
Yorum Gönder